A Phase III Randomised, Double Blind, Parallel-group Study of the Efficacy and Safety of Oral Dabigatran Etexilate (150mg bid) Compared to Warfarin (INR 2.0-3.0) for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism..........

Project: Research

Status	Finished
Effective start/end date	02/9/09 → 11/16/11

Project Details